Concepedia

Mimma Rizzo

MR

48

Publications

2K

Citations

24

H-Index

2009

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Istituto Oncologico Veneto

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Fondazione IRCCS Istituto Nazionale dei Tumori

University of Parma

Mimma Rizzo is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

2009–2024

48

Publications

48

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis

Giuseppe Di Lorenzo, Riccardo Autorino, Gianni Bruni et al. · Annals of Oncology · 2009 · 204 citations · Full text

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer

Giuseppe Di Lorenzo, Giacomo Cartenì, Riccardo Autorino et al. · Journal of Clinical Oncology · 2009 · 134 citations · Full text

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

Sergio Bracarda, Roberto Iacovelli, Luca Boni et al. · Annals of Oncology · 2015 · 105 citations · Full text

, , +5

Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors

Matteo Santoni, Alessandro Conti, Stefano Partelli et al. · Annals of Surgical Oncology · 2014 · 90 citations

, , +7

Rows per page

1–5 of 48